Publicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (14)

2023

  1. Non-invasive electromechanical assessment during atrial fibrillation identifies underlying atrial myopathy alterations with early prognostic value

    Nature communications, Vol. 14, Núm. 1, pp. 4613

2022

  1. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

2017

  1. Involvement of autophagy in NK cell development and function

    Autophagy

2016

  1. Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia

    Leukemia Research, Vol. 40, pp. 1-9

2014

  1. Gremlin activates the smad pathway linked to epithelial mesenchymal transdifferentiation in cultured tubular epithelial cells

    BioMed Research International, Vol. 2014

2013

  1. Effect of dual blockade of the renin-angiotensin system on the progression of type 2 diabetic nephropathy: A randomized trial

    American Journal of Kidney Diseases, Vol. 61, Núm. 2, pp. 211-218

  2. The C-terminal module IV of connective tissue growth factor is a novel immune modulator of the Th17 response

    Laboratory Investigation, Vol. 93, Núm. 7, pp. 812-824

2009

  1. The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients

    Blood, Vol. 114, Núm. 20, pp. 4369-4372

2008

  1. Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation

    Blood, Vol. 112, Núm. 10, pp. 4017-4023

  2. TWEAK, el facilitador del daño renal agudo

    Nefrologia

2005

  1. Aportación de la Tomografía por Emisión de Positrones (PET) al manejo de los tumores malignos de ovario y útero

    Oncologia, Vol. 28, Núm. 5, pp. 12-25

  2. Detection of stomach peritoneal infiltration in colorectal cancer using PET-FDG

    Clinical Nuclear Medicine, Vol. 30, Núm. 2, pp. 122-123

  3. Utilidad del PET-18FDG en la localizatión del tumor primario en un paciente con metástasis cerebrales

    Revista Espanola de Medicina Nuclear, Vol. 24, Núm. 4, pp. 253

2004

  1. La tomografía por emisión de positrones (PET) en la patología oncológica de cabeza y cuello

    Acta Otorrinolaringologica Espanola, Vol. 55, Núm. 7, pp. 303-309